{
    "SPADE_N_01247": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 7078380 B2",
                "Patent Link": "http://www.lens.org/lens/patent/US_7078380_B2",
                "Patent Type": "Granted Patent",
                "Publication Date": "2006-7-18",
                "Family Info": "CA2426012A1,EP1334117A1,EP1334117B1,US20040106544,WO2002036612A1",
                "Patent Title": "Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements.",
                "Abstract": "The invention concerns agents with anti-bacterial activity and methods and intermediates for their production. The present invention further concerns the use of such agents for the treatment of bacterial infections in animals, including man. The agents are derivatives of vancomycin-type antibiotics, of structure: V-L-W-X; wherein V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria; L is a linking group; W is a peptidic membrane-associating element such as an element based on naturally-occurring animal or bacterial peptide antibiotics; and X is hydrogen or a membrane-insertive element."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_01247",
            "Peptide Name": "Ranalexin (Frogs, amphibians, animals)",
            "Source": "Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLGGLIKIVPAMICAVTKKC",
            "Sequence Length": 20,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P39084"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "Gram-positive bacterium:Staphylococcus aureus (MIC=4 µg/ml);Gram-negative bacteria:Escherichia coli (MIC=32 µg/ml), Pseudomonas aeruginosa (MIC=128 µg/ml).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Cyclization (Cys14 and Cys20)",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C97H169N23O22S3",
            "Mass": 2105.72,
            "PI": 9.39,
            "Net Charge": 3,
            "Hydrophobicity": 1.4,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Function": "Potent microbicidal activity, active against S.aureus and E.coli. It acts as well as a membrane-disruptive agent at higher concentrations.",
            "Tissue specificity": "Expressed by the skin dorsal glands.",
            "Developmental stage": "Expression starts at metamorphosis and continues into adulthood.",
            "PTM": "Contains one disulfide bond 14-20.",
            "Literature": [
                {
                    "Title": "Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.",
                    "Pubmed ID": "8144672",
                    "Reference": "J Biol Chem. 1994 Apr 8;269(14)10849-10855.",
                    "Author": "Clark DP, Durell S, Maloy WL, Zasloff M.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=8144672"
                },
                {
                    "Title": "Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micelles.",
                    "Pubmed ID": "9578480",
                    "Reference": "Eur J Biochem. 1998 Apr 1;253(1)221-228.",
                    "Author": "Vignal E, Chavanieu A, Roch P, Chiche L, Grassy G, Calas B, Aumelas A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=9578480"
                }
            ],
            "Frequent Amino Acids": "IKA",
            "Absent Amino Acids": "DEHNOQRSUWY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 12,
            "Polar Residues": 10,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_07930",
                    "Similarity": 1.0,
                    "Sequence": "MFTLKKSLLLLFFLGTINLSLCEEERNAEEERRDNPDERDVEVEKRFLGGLIKIVPAMICAVTKKC"
                },
                {
                    "SPADE_ID": "SPADE_N_11237",
                    "Similarity": 1.0,
                    "Sequence": "FLGGLIKIVPAMICAVTKKCHHHHHH"
                },
                {
                    "SPADE_ID": "SPADE_UN_00393",
                    "Similarity": 1.0,
                    "Sequence": "FLGGLIKIVPAMICAVTKK"
                }
            ]
        }
    }
}